AbbVie Inc.
https://www.abbvie.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AbbVie Inc.
J&J Forecasts Strong Pharma Growth In 2021, But No COVID-19 Vaccine Update
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.
Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.
EU Crunch Time For Two Drugs That Lost Their Fast-Track Status
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.
Long Wait Ahead For Novartis's Leqvio In US
The timeline for a US resubmission of the closely watched PCSK9-targeting cholesterol treatment could be either Q2 or Q3 and approval will depend on whether the FDA needs to make a physical inspection of an Italian facility.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Mavupharma
- Pharmacyclics, Inc.
- Stemcentrx, Inc.
- Luminera